219 Users Online
Pacing Lead Market Segmented by Application type such as Unipolar pacing leads and Bipolar pacing leads
Pacing Leads are used for the transmission of electrical stimulation signals from the pacemaker to the heart itself. Pacing leads and its ability of the transmission of electrical signals to the hearts are essential for the success of any pacemaker operation or device. Pacing leads having demand of biostability, biocompatibility and electrical requirement.
In addition, pacing leads are ideal for long term implantable devices. Pacing leads are used during cardiovascular treatment. Pacing leads are minimally invasive medical devices that enable physicians to map the electrical system of the heart. When patient`s heart is not having sinus rhythm the cardiac output is not optimum. As pacing leads are placed to the myocardium after the cardiac surgery.
The electrical activity of the heart can be paced and sensed once the pacing leads are placed and connected to pacemaker. Pacing leads can be sited on the right ventricle, atrium or in both. When pacing leads are placed only in atrium or ventricle then it is known as single chamber pacing while when pacing leads are placed in both chamber then it is known as dual chamber pacing.
In single chamber pacing nearly invariably refers to employing the pacing lead on the right ventricle to make sure that the ventricles sufficiently pump blood through the body. However, if the ventricles or atria are not synchronized with each other, this often results in low cardiac output. While dual chamber pacing ensures the synchronization of atria and ventricles which results in the optimum cardiac output. However, placement of pacing lead on atrium can be lifesaving measure mainly when ventricular pacing is ineffectual.
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
The global Pacing Lead Market is driven by the increasing prevalence of cardiovascular disorders in developed nations, high disease occurrence in underdeveloped nations and various supportive government initiatives, and non-government organizations funding.
The increase in the overall health care spending and resistance to conventional treatment technique has benefitted the global Pacing Lead Market. The global Pacing Lead Market is likely to be restrained by the high cost of research and development in this sector. Lack of awareness and costly medications are some restrains to global Pacing Lead Market.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version| By Application type |
|
| By End User |
|
Based on application type, the global Pacing Lead Market is segmented into unipolar pacing leads and bipolar pacing leads. Similarly, based on end user, the market is segmented into, hospitals and online ambulatory surgical centers. Hospitals are expected to hold maximum share in the market due to higher rate of implants that take place in the hospitals segment as the reimbursement rates offered are better as compared to ambulatory surgical centers.
Sales Team
Client Partner
In terms of region, the global Pacing Lead Market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the leading player of Pacing Lead Market owing to increasing awareness and successful research in product innovations. Europe is the second leader in global Pacing Lead Market owing to development of devices and efficiency. Asia Pacific is also expected to grow due to increasing investment in health care spending and rise in research and development.
The key players in the market are Boston Scientific Corporation, Medtronic, Biomerics, Greatbatch Medical, LivaNova Plc, MEDICOWEB, Qinming Medical, St. Jude Medical and BIOTRONIK SE & Co. KG,
